Logo image of GNS

GENIUS GROUP LTD (GNS) Stock Fundamental Analysis

USA - NYSEARCA:GNS - SGXZ81555062 - Common Stock

1 USD
-0.09 (-8.26%)
Last: 9/15/2025, 8:04:01 PM
1.02 USD
+0.02 (+2%)
Pre-Market: 9/16/2025, 5:01:49 AM
Fundamental Rating

2

Taking everything into account, GNS scores 2 out of 10 in our fundamental rating. GNS was compared to 74 industry peers in the Diversified Consumer Services industry. The financial health of GNS is average, but there are quite some concerns on its profitability. GNS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GNS had negative earnings in the past year.
In the past year GNS has reported a negative cash flow from operations.
GNS had negative earnings in each of the past 5 years.
In the past 5 years GNS always reported negative operating cash flow.
GNS Yearly Net Income VS EBIT VS OCF VS FCFGNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

With a Return On Assets value of -24.62%, GNS is not doing good in the industry: 67.57% of the companies in the same industry are doing better.
The Return On Equity of GNS (-33.73%) is worse than 60.81% of its industry peers.
Industry RankSector Rank
ROA -24.62%
ROE -33.73%
ROIC N/A
ROA(3y)-32.95%
ROA(5y)-28.35%
ROE(3y)-284.46%
ROE(5y)-202.75%
ROIC(3y)N/A
ROIC(5y)N/A
GNS Yearly ROA, ROE, ROICGNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

GNS's Gross Margin of 32.64% is on the low side compared to the rest of the industry. GNS is outperformed by 62.16% of its industry peers.
In the last couple of years the Gross Margin of GNS has declined.
GNS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-7.99%
GNS Yearly Profit, Operating, Gross MarginsGNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

GNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
GNS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, GNS has more shares outstanding
GNS has a better debt/assets ratio than last year.
GNS Yearly Shares OutstandingGNS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
GNS Yearly Total Debt VS Total AssetsGNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 0.40, we must say that GNS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.40, GNS is doing worse than 63.51% of the companies in the same industry.
GNS has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
GNS's Debt to Equity ratio of 0.14 is fine compared to the rest of the industry. GNS outperforms 60.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 0.4
ROIC/WACCN/A
WACC8.65%
GNS Yearly LT Debt VS Equity VS FCFGNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 3.65 indicates that GNS has no problem at all paying its short term obligations.
The Current ratio of GNS (3.65) is better than 90.54% of its industry peers.
GNS has a Quick Ratio of 3.61. This indicates that GNS is financially healthy and has no problem in meeting its short term obligations.
GNS has a better Quick ratio (3.61) than 90.54% of its industry peers.
Industry RankSector Rank
Current Ratio 3.65
Quick Ratio 3.61
GNS Yearly Current Assets VS Current LiabilitesGNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

GNS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.33%.
The Revenue for GNS has decreased by -65.69% in the past year. This is quite bad
Measured over the past years, GNS shows a decrease in Revenue. The Revenue has been decreasing by -4.48% on average per year.
EPS 1Y (TTM)-13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-65.69%
Revenue growth 3Y-1.56%
Revenue growth 5Y-4.48%
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 38.61% on average over the next years. This is a very strong growth
GNS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.28% yearly.
EPS Next Y84.27%
EPS Next 2Y38.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.31%
Revenue Next 2Y10.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GNS Yearly Revenue VS EstimatesGNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
GNS Yearly EPS VS EstimatesGNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GNS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GNS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNS Price Earnings VS Forward Price EarningsGNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNS Per share dataGNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as GNS's earnings are expected to grow with 38.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.61%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GNS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENIUS GROUP LTD

NYSEARCA:GNS (9/15/2025, 8:04:01 PM)

Premarket: 1.02 +0.02 (+2%)

1

-0.09 (-8.26%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)N/A N/A
Inst Owners3.38%
Inst Owner Change-59.19%
Ins Owners8.85%
Ins Owner ChangeN/A
Market Cap87.81M
AnalystsN/A
Price Target4.39 (339%)
Short Float %4.2%
Short Ratio0.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-86.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.67%
EPS NY rev (3m)-16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-51.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.1
P/FCF N/A
P/OCF N/A
P/B 1.19
P/tB 1.64
EV/EBITDA N/A
EPS(TTM)-1.03
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0.09
BVpS0.84
TBVpS0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.62%
ROE -33.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.64%
FCFM N/A
ROA(3y)-32.95%
ROA(5y)-28.35%
ROE(3y)-284.46%
ROE(5y)-202.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-7.99%
F-Score1
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 344.67%
Cap/Sales 89.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.65
Quick Ratio 3.61
Altman-Z 0.4
F-Score1
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)138.36%
Cap/Depr(5y)102.77%
Cap/Sales(3y)32.99%
Cap/Sales(5y)23.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y84.27%
EPS Next 2Y38.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-65.69%
Revenue growth 3Y-1.56%
Revenue growth 5Y-4.48%
Sales Q2Q%N/A
Revenue Next Year-28.31%
Revenue Next 2Y10.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-311.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-273.5%
OCF growth 3YN/A
OCF growth 5YN/A